{"id":"NCT01638013","sponsor":"Astellas Pharma Inc","briefTitle":"A Study to Continue ASP015K Treatment to Rheumatoid Arthritis Patients Who Completed Phase IIb Study or Phase III Study of ASP015K","officialTitle":"Open-label Extension Study in Rheumatoid Arthritis Patients Who Have Completed Phase 2b Study or Phase 3 Study of ASP015K","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-06-13","primaryCompletion":"2019-09-30","completion":"2019-09-30","firstPosted":"2012-07-11","resultsPosted":"2020-10-23","lastUpdate":"2024-10-28"},"enrollment":843,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Arthritis, Rheumatoid"],"interventions":[{"type":"DRUG","name":"Peficitinib","otherNames":["ASP015K","Smyraf"]}],"arms":[{"label":"Participants who completed 015K-CL-RAJ1","type":"EXPERIMENTAL"},{"label":"Participants who completed 015K-CL-RAJ3","type":"EXPERIMENTAL"},{"label":"Participants who completed 015K-CL-RAJ4","type":"EXPERIMENTAL"}],"summary":"This study evaluated the safety and efficacy of long-term administration of ASP015K in patients who have completed Phase IIb or Phase III studies.","primaryOutcome":{"measure":"Number of Participants With Adverse Events","timeFrame":"Baseline up to end of study (EOS) (up to week 376)","effectByArm":[{"arm":"Participants Who Completed 015K-CL-RAJ1","deltaMin":193,"sd":null},{"arm":"Participants Who Completed 015K-CL-RAJ3","deltaMin":208,"sd":null},{"arm":"Participants Who Completed 015K-CL-RAJ4","deltaMin":395,"sd":null}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":5},"locations":{"siteCount":175,"countries":["Japan","South Korea","Taiwan"]},"refs":{"pmids":["33656739","32164762"],"seeAlso":["https://astellasclinicalstudyresults.com/study.aspx?ID=370"]},"adverseEventsSummary":{"seriousAny":{"events":59,"n":201},"commonTop":["Nasopharyngitis","Herpes zoster","Rheumatoid arthritis","Influenza","Blood creatine phosphokinase increased"]}}